Feasibility study of automated cardiac motion quantification to assess left ventricular function in type 2 diabetes

被引:0
|
作者
Yiming Li
Cungang Wu
Yuhong Li
机构
[1] First Affiliated Hospital With Jinzhou Medical University,Department of Medical Ultrasonics
来源
Scientific Reports | / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The global incidence of diabetes and related complications is gradually increasing, with cardiovascular complications being the leading cause of death in the diabetic population. The purpose of this study was to examine left ventricular function in individuals with type 2 diabetes mellitus (T2D) and conduct a feasibility analysis using automated cardiac motion quantification (aCMQ) approach. A total of 150 T2D patients with a history of diabetes mellitus dating back more than 10 years were chosen, and we treated 87 patients with T2D that had been present for less than 15 years as group I, 63 patients with T2D that had been present for more than 15 years as group II, and 50 healthy volunteers as the control group. From the three groups, clinical information, conventional ultrasonography parameters, and mitral annular plane systolic excursion (MAPSE) parameters were gathered. aCMQ technique was used to collect longitudinal strain and circumferential strain in the left ventricle. Tissue motion mitral annular displacement technique (TMAD) in aCMQ was used to collect parameters related to TMAD, and cardiac motion quantification (CMQ) was used to collect two-dimensional global longitudinal strain (2D-GLS) to compare the degree of difference between the aforementioned three groups. The differences between longitudinal strain groups in aCMQ were all statistically significant and gradually decreased with increasing disease duration. Most TMAD parameters were lower in groups I and II than in the control group, and TMAD parameters gradually decreased with increasing disease duration. The results of the LV global longitudinal strain and 2D-GLS using Bland–Altman analyses showed high agreement between and within groups, Pearson correlation analysis showed a significant positive correlation (r = 0.18, P < 0.05), and the AUC of ROC curves predicting the value of left ventricular function in patients with T2D was 0.723 and 0.628, respectively. With significant positive correlations between MAPSE, s', and the majority of the TAMD parameters (P < 0.05), TAMD, MAPSE, and s' demonstrated high inter- and intra-group agreement using Bland–Altman analyses, and the three had predictive value in assessing left ventricular function in T2D patients by ROC curve. Reduced longitudinal strain and reduced mitral annular displacement were seen in patients with different disease stages of T2D, so the application of aCMQ and TAMD was effective in detecting altered left ventricular function in patients with T2D. aCMQ had higher value in predicting left ventricular function in patients with T2D compared to CMQ for overall longitudinal strain, and the software performed the depiction automatically, reducing manual errors. MAPSE parameters and s ' can replace the TMAD technique for assessing mitral annular motion and was simpler to perform, saving operational time.
引用
收藏
相关论文
共 50 条
  • [21] Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
    Matsutani, Daisuke
    Sakamoto, Masaya
    Kayama, Yosuke
    Takeda, Norihiko
    Horiuchi, Ryuzo
    Utsunomiya, Kazunori
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [22] Functional capacity and left ventricular diastolic function in patients with type 2 diabetes
    Marijana Tadic
    Jelena Suzic-Lazic
    Vladan Vukomanovic
    Cesare Cuspidi
    Sanja Ilic
    Vera Celic
    Acta Diabetologica, 2021, 58 : 107 - 113
  • [23] Functional capacity and left ventricular diastolic function in patients with type 2 diabetes
    Tadic, Marijana
    Suzic-Lazic, Jelena
    Vukomanovic, Vladan
    Cuspidi, Cesare
    Ilic, Sanja
    Celic, Vera
    ACTA DIABETOLOGICA, 2021, 58 (01) : 107 - 113
  • [24] Longitudinal Development of Left Ventricular Diastolic Function in Patients With Type 2 Diabetes
    Venskutonyte, Laura
    Jarnert, Christina
    Ryden, Lars
    Kjellstrom, Barbro
    DIABETES CARE, 2014, 37 (11) : 3092 - 3097
  • [25] Association between steatohepatitis and left ventricular diastolic function in type 2 diabetes
    Huh, K.
    Cho, Y.
    Lee, M.
    Lee, Y. -H.
    Lee, B. -W.
    Kang, E.
    Ahn, C.
    Cha, B. -S.
    DIABETOLOGIA, 2017, 60 : S6 - S6
  • [26] Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
    Daisuke Matsutani
    Masaya Sakamoto
    Yosuke Kayama
    Norihiko Takeda
    Ryuzo Horiuchi
    Kazunori Utsunomiya
    Cardiovascular Diabetology, 17
  • [27] Usefulness of three-dimensional echocardiographic parametric quantification of regional left ventricular function: A feasibility study
    Soliman, Osama I.
    Kirschbaum, Sharon W.
    Geleijnse, Marcel L.
    Nemes, Attila
    Krenning, Boudewijn J.
    van Dalen, Bas M.
    Vletter, Wim B.
    van Geuns, Robert-Jan
    Al-Amin, Aly M.
    Ten Cate, Folkert J.
    CIRCULATION, 2007, 116 (16) : 400 - 401
  • [28] Automated quantification of left-ventricular volumes and function: A novel clinical tool?
    Lipiec, P
    Plewka, M
    Krzeminska-Pakula, M
    Drozdz, J
    Ciesielczyk, M
    Wejner-Mik, P
    Kasprzak, JD
    EUROPEAN HEART JOURNAL, 2003, 24 : 313 - 313
  • [29] Effects of pemafibrate on left ventricular diastolic function in patients with type 2 diabetes mellitus: a pilot study
    Yamamoto, Kaoru
    Ohta, Yasuharu
    Taguchi, Akihiko
    Akiyama, Masaru
    Nakabayashi, Hiroko
    Nagao, Yuko
    Ryoko, Hatanaka
    Wada, Yasuaki
    Yamamoto, Takeshi
    Yano, Masafumi
    Tanizawa, Yukio
    DIABETOLOGY INTERNATIONAL, 2023, 14 (04) : 434 - 439
  • [30] Effects of pemafibrate on left ventricular diastolic function in patients with type 2 diabetes mellitus: a pilot study
    Kaoru Yamamoto
    Yasuharu Ohta
    Akihiko Taguchi
    Masaru Akiyama
    Hiroko Nakabayashi
    Yuko Nagao
    Hatanaka Ryoko
    Yasuaki Wada
    Takeshi Yamamoto
    Masafumi Yano
    Yukio Tanizawa
    Diabetology International, 2023, 14 : 434 - 439